Defining human mesenchymal stem cell efficacy in vivo

Allogeneic human mesenchymal stem cells (hMSCs) can suppress graft versus host disease (GvHD) and have profound anti-inflammatory and regenerative capacity in stroke, infarct, spinal cord injury, meniscus regeneration, tendinitis, acute renal failure, and heart disease in human and animal models of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bonfield, Tracey L, Nolan (Koloze), Mary T, Lennon, Donald P, Caplan, Arnold I
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2010
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2987779/
https://ncbi.nlm.nih.gov/pubmed/20974000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-9255-7-51
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars